CAMBRIDGE, Mass.--(BUSINESS WIRE)--ARIAD Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will present at the Oppenheimer 22nd Annual Healthcare Conference in New York City. Harvey J. Berger, M.D., chairman and chief executive officer, will provide an overview of the Company’s oncology pipeline on Tuesday, December 13 at 9:40 a.m. (ET).
